HIV disease and advanced age: an increasing therapeutic challenge (Q34967154)

5 August 2017

1 reference

title

HIV disease and advanced age: an increasing therapeutic challenge (English)

1 reference

5 August 2017

Roberto Manfredi

1

1 reference

5 August 2017

1 January 2002

1 reference

5 August 2017

1 reference

5 August 2017

19

1 reference

5 August 2017

647-669

1 reference

5 August 2017

9

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200219090-00003

5 August 2017

0 references

cites work

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

1 reference

12 December 2020

Development and Significance of the HIV-1 Reverse Transcriptase M184V Mutation During Combination Therapy With Lamivudine, Zidovudine, and Protease Inhibitors

1 reference

12 December 2020

Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy

1 reference

12 December 2020

Effect of Highly Active Antiretroviral Therapy and Thymic Transplantation on Immunoreconstitution in HIV Infection

1 reference

12 December 2020

Antiviral effect and pharmacokinetic interaction between nevirapine and indinavir in persons infected with human immunodeficiency virus type 1.

1 reference

12 December 2020

Gynecomastia associated with highly active antiretroviral therapy

1 reference

12 December 2020

Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor.

1 reference

12 December 2020

HIV-associated lipodystrophy syndrome

1 reference

12 December 2020

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

12 December 2020

Changes in thymic function with age and during the treatment of HIV infection

1 reference

12 December 2020

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

12 December 2020

Switch of protease inhibitor-containing HAART in routine clinical practice: a four-year prospective observational study

1 reference

12 December 2020

Immune repopulation after HAART in previously untreated HIV-1-infected children. Paediatric European Network for Treatment of AIDS (PENTA) Steering Committee.

1 reference

12 December 2020

Does use of potent antiretroviral therapy differ by health care setting?

1 reference

12 December 2020

The effects of alternative treatments for HIV disease on recommended pharmacological regimens

1 reference

12 December 2020

Occult HIV infection: diagnosis and treatment of older patients

1 reference

12 December 2020

Predictors of Virological Success and Ensuing Failure in HIV-Positive Patients Starting Highly Active Antiretroviral Therapy in Europe

1 reference

12 December 2020

Management of the adverse effects of antiretroviral therapy and medication adherence

1 reference

12 December 2020

Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate

1 reference

12 December 2020

Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy

1 reference

12 December 2020

Decreased medical expenditures for care of HIV-seropositive patients. The impact of highly active antiretroviral therapy at a US Veterans Affairs Medical Center

1 reference

12 December 2020

Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens

1 reference

12 December 2020

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy

1 reference

12 December 2020

Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development

1 reference

12 December 2020

The cost of HIV treatment and care. A global review

1 reference

12 December 2020

Impact of drug resistance mutations on virologic response to salvage therapy

1 reference

12 December 2020

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

12 December 2020

Unusual distributions of body fat in AIDS patients: a review of adverse events reported to the Food and Drug Administration

1 reference

12 December 2020

Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical development

1 reference

12 December 2020

How long may perinatally acquired human immunodeficiency virus infection last asymptomatically?

1 reference

12 December 2020

Marked declines in human immunodeficiency virus-related mortality in Chicago in women, African Americans, Hispanics, young adults, and injection drug users, from 1995 through 1997.

1 reference

12 December 2020

Decreased recovery of CD4 lymphocytes in older HIV-infected patients beginning highly active antiretroviral therapy

1 reference

12 December 2020

Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume

1 reference

12 December 2020

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

1 reference

12 December 2020

Therapeutic and diagnostic procedures in hospitalized AIDS patients with terminal illness

1 reference

12 December 2020

Thymic involution and HIV progression

1 reference

12 December 2020

Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy

1 reference

12 December 2020

AIDS diagnoses at higher CD4 counts in Australia following the introduction of highly active antiretroviral treatment

1 reference

12 December 2020

Acquired immunodeficiency syndrome in the elderly

1 reference

12 December 2020

Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome

1 reference

12 December 2020

A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.

1 reference

12 December 2020

Quantification of the impact of HIV-1 reverse transcriptase and protease mutations on the efficacy of rescue HAART.

1 reference

12 December 2020

Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases

1 reference

12 December 2020

Stavudine and the peripheral nerve in HIV-1 infected patients.

1 reference

12 December 2020

Switch to an antiretroviral treatment of expected lower potency after effective highly active antiretroviral therapy (HAART)

1 reference

12 December 2020

Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study

1 reference

12 December 2020

Antiretroviral therapy in HIV infection: are we using resources appropriately and cost effectively?

1 reference

12 December 2020

Osteonecrosis and highly active antiretroviral therapy during HIV infection: report of a series and literature review

1 reference

12 December 2020

Limits of deep salvage antiretroviral therapy with nelfinavir plus either efavirenz or nevirapine, in highly pre-treated patients with HIV disease

1 reference

12 December 2020

Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort Study.

1 reference

12 December 2020

Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy

1 reference

12 December 2020

Recurrent 'Migrainelike' Episodes in Patients With HIV Disease

1 reference

12 December 2020

Function of the thymus in HIV-infected adults

1 reference

12 December 2020

The cost effectiveness of combination antiretroviral therapy for HIV disease.

1 reference

12 December 2020

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

12 December 2020

Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study.

1 reference

12 December 2020

Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons

1 reference

12 December 2020

Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: clinical and genotypic predictors of virologic response

1 reference

12 December 2020

Update on antiviral DNA vaccine research (1998-2000).

1 reference

12 December 2020

Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy

1 reference

12 December 2020

Lack of change in the distribution of AIDS-defining opportunistic diseases and the related degree of immunodeficiency during the periods before and after the introduction of highly active antiretroviral therapy

1 reference

12 December 2020

Substitution of protease inhibitors during treatment of patients with human immunodeficiency virus infection: frequency, mode, reasons and mid-term outcome

1 reference

12 December 2020

Mortality for Liver Disease in Patients With HIV Infection: A Cohort Study

1 reference

12 December 2020

Hit HIV-1 hard, but only when necessary

1 reference

12 December 2020

Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection

1 reference

12 December 2020

Determinants of progression to AIDS in HIV-infected individuals: an update from the Italian Seroconversion Study.

1 reference

12 December 2020

Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre.

1 reference

12 December 2020

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Effect of HIV on thymic function before and after antiretroviral therapy in children

1 reference

12 December 2020

Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.

1 reference

12 December 2020

A Randomized, Double-Blind Trial on the Use of a Triple Combination Including Nevirapine, a Nonnucleoside Reverse Transcriptase HIV Inhibitor, in Antiretroviral-Naive Patients With Advanced Disease

1 reference

12 December 2020

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

1 reference

12 December 2020

Race, sex, drug use, and progression of human immunodeficiency virus disease

1 reference

12 December 2020

Evidence for thymic function in the elderly

1 reference

12 December 2020

Antiretroviral adherence and use of alternative therapies among older HIV-infected adults

1 reference

12 December 2020

Quality of life in maintenance vs prolonged induction therapy for HIV.

1 reference

12 December 2020

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

1 reference

12 December 2020

A case-control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age

1 reference

12 December 2020

Human immunodeficiency virus type 1 infection: relationship of risk group and age to rate of progression to AIDS. Transfusion Safety Study Group

1 reference

12 December 2020

Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen.

1 reference

12 December 2020

Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy

1 reference

12 December 2020

Influences of age, viral load, and CD4+ count on the rate of progression of HIV-1 infection to AIDS. Transfusion Safety Study Group

1 reference

12 December 2020

Clinical utility of testing human immunodeficiency virus for drug resistance

1 reference

12 December 2020

Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic

1 reference

12 December 2020

Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy

1 reference

12 December 2020

Economic costs of HIV/AIDS prevention activities in sub-Saharan Africa.

1 reference

12 December 2020

Metabolic disorders among HIV-infected patients treated with protease inhibitors: a review

1 reference

12 December 2020

Recovery of the immune system with antiretroviral therapy: the end of opportunism?

1 reference

12 December 2020

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

1 reference

12 December 2020

Association of initial CD4 cell count and viral load with response to highly active antiretroviral therapy

1 reference

12 December 2020

The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine. Prometheus Study Group

1 reference

12 December 2020

Functional reconstitution of thymopoiesis after human immunodeficiency virus infection.

1 reference

12 December 2020

Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group.

1 reference

12 December 2020

The decline in CD4+ T lymphocytes as a function of the duration of HIV infection, age at seroconversion, and viral load

1 reference

12 December 2020

Modeling the Long-Term Outcomes and Costs of HIV Antiretroviral Therapy Using HIV RNA Levels: Application to a Clinical Trial

1 reference

12 December 2020

HIV and the older adult

1 reference

12 December 2020

Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy

1 reference

12 December 2020

Costs of HIV medical care in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Influence of age at infection on human immunodeficiency virus disease progression to different clinical endpoints: the SEROCO cohort (1988-1994). The Seroco Study Group

1 reference

12 December 2020

Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group

1 reference

12 December 2020

Protease inhibitors: resistance, cross-resistance, fitness and the choice of initial and salvage therapies.

1 reference

12 December 2020

1 reference

12 December 2020

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

12 December 2020

Progress in HIV therapeutics and the challenges of adherence to antiretroviral therapy

1 reference

12 December 2020

Dual nucleoside analogue treatment in the era of highly active antiretroviral therapy (HAART): a single-centre cross-sectional survey

1 reference

12 December 2020

Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).

1 reference

12 December 2020

CD4 cell counts at the third month of HAART may predict clinical failure.

1 reference

12 December 2020

[Antiretroviral therapy in HIV infection. Effects of the introduction of new drugs on health care expenditures, 1994-1999]

1 reference

12 December 2020

Syndrome of recurrent transient neurological deficits in patients with HIV infection

1 reference

12 December 2020

Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities

1 reference

12 December 2020

Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations

1 reference

12 December 2020

Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Opportunistic infections occurring during highly active antiretroviral treatment

1 reference

12 December 2020

Understanding delay to medical care for HIV infection: the long-term non-presenter

1 reference

12 December 2020

Cost effectiveness of combination HIV therapy: 3 years later

1 reference

12 December 2020

Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients

1 reference

12 December 2020

Elevated lactate levels in hospitalized persons with HIV infection

1 reference

12 December 2020

Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy.

1 reference

12 December 2020

Management of dyslipidemia in patients with HIV disease

1 reference

12 December 2020

Unrecognized human immunodeficiency virus infection in the elderly

1 reference

12 December 2020

Salvage antiretroviral therapy.

1 reference

12 December 2020

Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine.

1 reference

12 December 2020

Thymus volume correlates with the progression of vertical HIV infection

1 reference

12 December 2020

Clinical and immunologic response without decrease in virus load in patients with AIDS after 24 months of highly active antiretroviral therapy

1 reference

12 December 2020

Features of AIDS and AIDS defining diseases during the highly active antiretroviral therapy (HAART) era, compared with the pre-HAART period: a case control study

1 reference

12 December 2020

HIV infection and aging: mechanisms to explain the accelerated rate of progression in the older patient

1 reference

12 December 2020

A randomized trial comparing the introduction of ritonavir or indinavir in 1251 nucleoside-experienced patients with advanced HIV infection.

1 reference

12 December 2020

Economic evaluation of drug resistance genotyping for the adaptation of treatment in HIV-infected patients in the VIRADAPT study

1 reference

12 December 2020

Thymic involution with ageing: obsolescence or good housekeeping?

1 reference

12 December 2020

Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus G

1 reference

12 December 2020

Discordance between virological, immunologic, and clinical outcomes of therapy with protease inhibitors among human immunodeficiency virus-infected patients

1 reference

12 December 2020

Is age a negative prognostic indicator in HIV infection or AIDS?

1 reference

12 December 2020

ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results.

1 reference

12 December 2020

Factors affecting adherence to antiretroviral therapy

1 reference

12 December 2020

Attaining higher goals in HIV treatment: the central importance of adherence

1 reference

12 December 2020

The changing face of AIDS-related opportunism: cryptococcosis in the highly active antiretroviral therapy (HAART) era. Case reports and literature review

1 reference

12 December 2020

Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1-infected Italian patients with virologic failure

1 reference

12 December 2020

First-line nevirapine in combination with nucleoside analogues compared with nevirapine added to a salvage HAART

1 reference

12 December 2020

Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection

1 reference

12 December 2020

A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study

1 reference

12 December 2020

Effect of gender, age, transmission category, and antiretroviral therapy on the progression of human immunodeficiency virus infection using multistate Markov models. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine

1 reference

12 December 2020

Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. Swiss HIV Cohort Study.

1 reference

12 December 2020

Human immunodeficiency virus infection in elderly patients

1 reference

12 December 2020

10.2165/00002512-200219090-00003

Identifiers

DOI

1 reference

PubMed ID

12381235

Dimensions Publication ID

5 August 2017

0 references

1 reference

PubMed ID

12381235